<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00627406</url>
  </required_header>
  <id_info>
    <org_study_id>N-VN-2002-0046MCH</org_study_id>
    <nct_id>NCT00627406</nct_id>
  </id_info>
  <brief_title>Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles</brief_title>
  <official_title>A Prospective Randomised Study to Evaluate the Effect of Triggering Ovulation With GnRHa (Buserelin) and Low Dose hCG (Pregnyl) as Compared to the Use of Conventional Doses of hCG (Pregnyl)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regionshospitalet Viborg, Skive</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to possibly further improve the clinical outcome and explore the
      incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in
      GnRH antagonist IVF/ICSI cycles
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of Moderate to Severe OHSS.</measure>
    <time_frame>From the date of triggering ovulation until 2 weeks after pregnancy test. group C and D. 12 days after pregnancy test</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>from stimulation day 1 until last ultrasound scan 7 weeks after a positive pregnancy test</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">384</enrollment>
  <condition>OHSS (Ovarian Hyperstimulation)</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buserelin and Pregnyl</intervention_name>
    <description>Subcutaneous injection 0.5 mg and 1500 IU</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregnyl</intervention_name>
    <description>Subcutaneous injection 5000 IU</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buserelin and Pregnyl</intervention_name>
    <description>Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregnyl</intervention_name>
    <description>Subcutaneous injection 5000 IU</description>
    <arm_group_label>D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient complying with the conditions for IVF or ICSI treatment

          -  Female age over 20 years and under 40 years

          -  Normal regular cycle and patients with oligomenorrhea

          -  BMI &gt; 18 and &lt; 35

          -  each patient contributes with one cycle only

        Exclusion Criteria:

          -  Significant disturbances in the woman (diabetes, epilepsy, liver/renal/heart disease,
             metabolic disorder)

          -  Patients with &gt; 25 follicles on the day of triggering ovulation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter S Humaidan, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>The Fertility Clinic, Regional Hospital of Skive</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2008</study_first_submitted>
  <study_first_submitted_qc>February 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2008</study_first_posted>
  <results_first_submitted>September 25, 2013</results_first_submitted>
  <results_first_submitted_qc>September 25, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 27, 2013</results_first_posted>
  <last_update_submitted>September 25, 2013</last_update_submitted>
  <last_update_submitted_qc>September 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>Prof. M.D. D.M.Sc.</investigator_title>
  </responsible_party>
  <keyword>GnRH antagonist</keyword>
  <keyword>GnRH agonist</keyword>
  <keyword>hCG</keyword>
  <keyword>OHSS</keyword>
  <keyword>In vitro fertilization</keyword>
  <keyword>ovulation induction</keyword>
  <keyword>Clinical pregnancy rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorionic Gonadotropin</mesh_term>
    <mesh_term>Buserelin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period from jan. 2009 to dec. 2011. Participanting Clinics Fertility clinic Regional Hospital Skive, University Hostipal Odense, Regional Hospital Holbaek, Denmark.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>A: &gt;14 Follicles; GnRHa Trigger + 1500 hCG</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)
Buserelin and Pregnyl : Subcutaneous injection 0.5 mg and 1500 IU</description>
        </group>
        <group group_id="P2">
          <title>B: &gt;14 Follicles; hCG Trigger</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
        <group group_id="P3">
          <title>C:&lt;15 Follicles; GnRHa Trigger + 1500 hCG x 2</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)
Buserelin and Pregnyl : Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
        </group>
        <group group_id="P4">
          <title>D: &lt;15 Follicles; hCG Trigger</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="125"/>
                <participants group_id="P4" count="141"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="125"/>
                <participants group_id="P4" count="141"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>A: &gt;14 Follicles; GnRHa Trigger + 1500 hCG</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)
Buserelin and Pregnyl : Subcutaneous injection 0.5 mg and 1500 IU</description>
        </group>
        <group group_id="B2">
          <title>B: &gt;14 Follicles; hCG Trigger</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
        <group group_id="B3">
          <title>C:&lt;15 Follicles; GnRHa Trigger + 1500 hCG x 2</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)
Buserelin and Pregnyl : Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
        </group>
        <group group_id="B4">
          <title>D: &lt;15 Follicles; hCG Trigger</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
            <count group_id="B2" value="58"/>
            <count group_id="B3" value="125"/>
            <count group_id="B4" value="141"/>
            <count group_id="B5" value="384"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="125"/>
                    <measurement group_id="B4" value="141"/>
                    <measurement group_id="B5" value="384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.5" spread="5.2"/>
                    <measurement group_id="B2" value="29.8" spread="3.8"/>
                    <measurement group_id="B3" value="30.8" spread="3.9"/>
                    <measurement group_id="B4" value="31.5" spread="3.7"/>
                    <measurement group_id="B5" value="30.2" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="125"/>
                    <measurement group_id="B4" value="141"/>
                    <measurement group_id="B5" value="384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="125"/>
                    <measurement group_id="B4" value="141"/>
                    <measurement group_id="B5" value="384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Frequency of Moderate to Severe OHSS.</title>
        <time_frame>From the date of triggering ovulation until 2 weeks after pregnancy test. group C and D. 12 days after pregnancy test</time_frame>
        <population>No power calculation was proformed.</population>
        <group_list>
          <group group_id="O1">
            <title>A: &gt;14 Follicles; GnRHa Trigger + 1500 hCG</title>
            <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)
Buserelin and Pregnyl : Subcutaneous injection 0.5 mg and 1500 IU</description>
          </group>
          <group group_id="O2">
            <title>B: &gt;14 Follicles; hCG Trigger</title>
            <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
          </group>
          <group group_id="O3">
            <title>C:&lt;15 Follicles; GnRHa Trigger + 1500 hCG x 2</title>
            <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)
Buserelin and Pregnyl : Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
          </group>
          <group group_id="O4">
            <title>D: &lt;15 Follicles; hCG Trigger</title>
            <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
          </group>
        </group_list>
        <measure>
          <title>Frequency of Moderate to Severe OHSS.</title>
          <population>No power calculation was proformed.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="125"/>
                <count group_id="O4" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pregnancy Rate</title>
        <time_frame>from stimulation day 1 until last ultrasound scan 7 weeks after a positive pregnancy test</time_frame>
        <group_list>
          <group group_id="O1">
            <title>A: &gt;14 Follicles; GnRHa Trigger + 1500 hCG</title>
            <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)
Buserelin and Pregnyl : Subcutaneous injection 0.5 mg and 1500 IU</description>
          </group>
          <group group_id="O2">
            <title>B: &gt;14 Follicles; hCG Trigger</title>
            <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
          </group>
          <group group_id="O3">
            <title>C:&lt;15 Follicles; GnRHa Trigger + 1500 hCG x 2</title>
            <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)
Buserelin and Pregnyl : Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
          </group>
          <group group_id="O4">
            <title>D: &lt;15 Follicles; hCG Trigger</title>
            <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy Rate</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="125"/>
                <count group_id="O4" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>A: &gt;14 Follicles; GnRHa Trigger + 1500 hCG</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)
Buserelin and Pregnyl : Subcutaneous injection 0.5 mg and 1500 IU</description>
        </group>
        <group group_id="E2">
          <title>B: &gt;14 Follicles; hCG Trigger</title>
          <description>More than 14 follicles with a diameter of &gt; 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
        <group group_id="E3">
          <title>C:&lt;15 Follicles; GnRHa Trigger + 1500 hCG x 2</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)
Buserelin and Pregnyl : Subcutaneous injection 0,5 mg and 1500 IU + 1500 IU after 7 days</description>
        </group>
        <group group_id="E4">
          <title>D: &lt;15 Follicles; hCG Trigger</title>
          <description>14 or less follicles with a diameter of &gt; 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)
Pregnyl : Subcutaneous injection 5000 IU</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="141"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="141"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Peter Humaidan</name_or_title>
      <organization>Fertility Clinic Regional Hospital Skive</organization>
      <phone>+45 78 44 57 60</phone>
      <email>peter.humaidan@viborg.rm.dk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

